The Russian Federation is one of six Gavi AMC donors. In February 2007, Russia committed US$ 80 million for the period of 2010–2019 to launch the first Advance Market Commitment (AMC) to help accelerate the development and availability of pneumococcal vaccines.

Proceeds to Gavi 6.0 as of 30 June 2026†
Contributions to Gavi Board approved financing instruments

*Local currency

†Proceeds are the funds that Gavi receives from donor commitments, either through direct donor payments, funding raised in advance against future donor pledges through IFFIm, or AMC funds released by the World Bank.

Contributions and pledges per strategic period (US$ millions)

Hover over the bar chart above to view the data

Direct Contributions (including Matching Fund)

Non-US$ contributions are converted to US$ as follows:

  • Before Gavi 6.0 (2000–2025): exchange rate on date of receipt; where hedged (2014–2025), the hedge rate applies instead.
  • Gavi 6.0 (2026 onward, received & future contributions and Matching Fund Pledges): Bloomberg replenishment rate, 16:00 London time, 25 June 2025.

IFFIm Contributions

Non-US$ contributions are converted to US$ as follows:

  • Received Contributions: rate confirmed by the World Bank's International Bank for Reconstruction and Development (IBRD).
  • Future, signed contribution agreements: exchange rate at time of signing.
  • Future, unsigned contribution agreements: Bloomberg replenishment rate, 16:00 London time, 25 June 2025.

 

All donors